Is Altimmune, Inc. (ALT) Still a Buy After Price Target Reduction to $20?

Stocks Yahoo Finance By Yahoo Finance 24 Jun 2026 13:26 1 min read

Is Altimmune, Inc. (ALT) Still a Buy After Price Target Reduction to $20?

Is Altimmune, Inc. (ALT) Still a Buy After Price Target Reduction to $20?

Is Altimmune, Inc. (ALT) Still a Buy After Price Target Reduction to $20?

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.